Retrieve available abstracts of 75 articles: HTML format
Single Articles
June 2025
MENDEZ LM, DeAngelo DJ, Luskin MR Treatment of Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative
Acute Lymphoblastic Leukemia.
Acta Haematol. 2025 Jun 10:1-22. doi: 10.1159/000546381. PubMedAbstract available
May 2025
MCCALL D, Catueno S, Ramakrishnan R, Tewari P, et al Beyond Cellular Therapies: The Expanding Role of Antibody-Driven Immunotherapy in
Pediatric Acute Lymphoblastic Leukemia.
Acta Haematol. 2025 May 5:1-31. doi: 10.1159/000546249. PubMedAbstract available
LE COUTRE P, Burchert A, Saussele S, Schwarzer T, et al Favorable rates of cardiovascular events with stringent cardiovascular monitoring
and a lowered dose of ponatinib as second line treatment in chronic phase chronic
myeloid leukemia (CML-CP) patients failing or intolerant to first-line second
generatio
Acta Haematol. 2025 May 5:1-13. doi: 10.1159/000545826. PubMedAbstract available
April 2025
SHERBAN A, Frisch A, Rozental A, Buchrits S, et al Epiglottitis in Patients Treated for Acute Leukemia - Case Series and Systematic
Review of the Literature.
Acta Haematol. 2025 Apr 17:1-21. doi: 10.1159/000545927. PubMedAbstract available
YAO X, Wang H, Yang L Global, regional, and national burden of leukemia, 1990-2021: a systematic
analysis for the global burden of disease study 2021.
Acta Haematol. 2025 Apr 14:1-27. doi: 10.1159/000545724. PubMedAbstract available
ZEIDAN AM, Yu R, Wang Y, Lan Z, et al STREAMLINE - Retrospective Cohort Study of FMS-like Tyrosine Kinase 3-Mutated
Acute Myeloid Leukemia: Real-World Treatment Patterns and Clinical Outcomes of
Patients in First Relapse or Refractory Diagnosis.
Acta Haematol. 2025 Apr 14:1-20. doi: 10.1159/000545384. PubMedAbstract available
GILBERT JS, Pollyea DA, Walsh TJ, Groll AH, et al Recombinant myeloid hematopoietic growth factors and clinical stimulation of
acute myeloid leukemia cells: a narrative review.
Acta Haematol. 2025 Apr 8:1-15. doi: 10.1159/000545588. PubMedAbstract available
March 2025
NANDURI AC, Ashraf F, Hlaing SS, Brister M, et al Acute Promyelocytic Leukemia Presenting with Cranial Nerve Involvement and Clivus
Mass.
Acta Haematol. 2025 Mar 29:1-15. doi: 10.1159/000545444. PubMedAbstract available
SHAPIRA S, Mizrahi B, Hirschberger N, Rabinowicz N, et al Mind-Body Intervention in Chronic Lymphocytic Leukemia During the Watch-and-Wait
Phase: Benefits Linked to Intervention Duration.
Acta Haematol. 2025 Mar 24:1-6. doi: 10.1159/000545407. PubMedAbstract available
SEYITHANOGLU D, Sert EN, Ozbalak M, Mastanzade M, et al The Effect of T-Lymphocyte Subgroups at Diagnosis on The Prognosis of Chronic
Lymphocytic Leukemia.
Acta Haematol. 2025 Mar 17:1-11. doi: 10.1159/000545269. PubMedAbstract available
MCCALL D, Karol SE, Short NJ The Need for Concurrent Chemoimmunotherapy in Pediatric B-Cell Lymphoblastic
Leukemia.
Acta Haematol. 2025 Mar 7:1-7. doi: 10.1159/000545028. PubMed
January 2025
OANUNU U, Gross Even Zohar N, Aumann S, Vainstein V, et al Prognostic Factors, FLT-3 Mutations, and Treatment Outcomes with pediatric
inspired protocols in adolescent and young adults (AYA) and adult patients with
Acute Lymphoblastic Leukemia.
Acta Haematol. 2025 Jan 30:1-24. doi: 10.1159/000543861. PubMedAbstract available
LV W, Wang Y, Hu F, Huang H, et al A prognostic survival model based on endocrine-related gene expression in acute
myelogenous leukemia.
Acta Haematol. 2025 Jan 14:1-21. doi: 10.1159/000543272. PubMedAbstract available
CHO HJ, Baek DW, Kim J, Jang YE, et al Real-World Experience in the Management of Chronic Myeloid Leukemia Patients
Focused on Tyrosine Kinase Inhibitors Intolerance and Health-Related Quality of
Life.
Acta Haematol. 2025 Jan 10:1-14. doi: 10.1159/000542562. PubMedAbstract available
ROEKER LE, Coombs CC, Shah NN, Jurczak W, et al Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell
Malignancies.
Acta Haematol. 2025;148:180-197. PubMedAbstract available
BRUNO DS, Khanal M, Li XI, Escalon MP, et al Racial and Ethnic Characteristics and Outcomes of Patients Diagnosed with CLL/SLL
in the USA.
Acta Haematol. 2025;148:148-162. PubMedAbstract available
DRAGOI OD, Shah M, Potter V, Avenoso D, et al Disseminated Mucormycosis and T-Cell-Depleted Allogeneic Stem Cell
Transplantation: An Unusual Case Study.
Acta Haematol. 2025;148:362-368. PubMedAbstract available
December 2024
DAUNGSUPAWONG H, Wiwanitkit V Haploidentical allogeneic hematopoietic cell transplantation following two
courses of venetoclax and azacytidine therapy in patients over 55 years old with
acute myelogenous leukemia: Comment.
Acta Haematol. 2024 Dec 2:1-3. doi: 10.1159/000542843. PubMed
October 2024
KONG J, Miao W, Lu J, Liu Y, et al Shorter duration of Blinatumomab administration to 14 days has same efficacy and
safety profile in treatment of relapsed/refractory B-cell precursor acute
lymphoblastic leukemia: A retrospective single-center study.
Acta Haematol. 2024 Oct 28:1-10. doi: 10.1159/000542060. PubMedAbstract available
CAO J, Zhuang X, Luo D, Pei R, et al Efficacy of haploidentical allogeneic hematopoietic cell transplantation
following two courses of venetoclax and azacytidine therapy in patients over 55
years old with acute myelogenous leukemia.
Acta Haematol. 2024 Oct 25:1-18. doi: 10.1159/000542034. PubMedAbstract available
LIANG Q, Liu Z, Wu Y, Zhu H, et al Sudden Blast Crisis in a chronic myeloid leukemia patient in Treatment Free
Remission: A case report and literature review.
Acta Haematol. 2024 Oct 21:1-16. doi: 10.1159/000542153. PubMedAbstract available
September 2024
TADMOR T, Melamed G, Alapi H, Gazit S, et al Intake of Proton Pump Inhibitors is Associated with a Shorter Time To First
Treatment in early-stage Chronic Lymphocytic Leukemia.
Acta Haematol. 2024 Sep 30:1-9. doi: 10.1159/000541453. PubMedAbstract available
IURLO A, Bucelli C, Intermesoli T, Elena C, et al BOSUTINIB TREATMENT OF CHRONIC MYELOID LEUKEMIA IN LOMBARDY.
Acta Haematol. 2024 Sep 18:1-13. doi: 10.1159/000540572. PubMedAbstract available
June 2024
NIEHUS HD, Sabile J, Maziarz RT, Meyers G, et al Enhanced Survival of Chronic Myelomonocytic Leukemia (CMML)-Dysplastic over
Proliferative Subtype After Allogeneic Hematopoietic Cell Transplant: A Tertiary
Center Experience and Literature Review.
Acta Haematol. 2024 Jun 26. doi: 10.1159/000539880. PubMedAbstract available
MARVIN-PEEK J, Shelton V, Brassil K, Fellman B, et al Effect of Digital Health Coaching on Self-Efficacy and Patient Reported Outcomes
in Individuals with Acute Myeloid and Chronic Lymphocytic Leukemia: A Pilot
Randomized Controlled Trial.
Acta Haematol. 2024 Jun 11. doi: 10.1159/000539756. PubMedAbstract available
May 2024
LIU Y, Ning Y, Ghiaur G, Emadi A, et al Biologic and clinical characteristics of isochromosome der(17)(q10)t(15;17) in
acute promyelocytic leukemia.
Acta Haematol. 2024 May 31. doi: 10.1159/000539159. PubMedAbstract available
ZENG X, Liu K, Xu R, Zhang L, et al TES and SLC40A1 as potential biomarkers for predicting survival in T-cell acute
lymphoblastic leukemia.
Acta Haematol. 2024 May 28. doi: 10.1159/000539435. PubMedAbstract available
DAMPMANN M, Flossdorf S, Keyl J, Reinhardt HC, et al Single-center experience of patients with plasma cell leukemia in the era of new
therapeutics.
Acta Haematol. 2024 May 19. doi: 10.1159/000539223. PubMedAbstract available
April 2024
JIN X, Jiang X, Li H, Shen K, et al Prognostic Implications of Circulating Plasma Cell Percentage in Multiple Myeloma
and Primary Plasma Cell Leukemia Defined by New Criteria.
Acta Haematol. 2024 Apr 16. doi: 10.1159/000538658. PubMedAbstract available
NASNAS PE, Jabbour EJ, Sasaki K, Issa GC, et al Failure of treatment-free remission after a prolonged deep molecular response in
patients with chronic myeloid leukemia.
Acta Haematol. 2024 Apr 4. doi: 10.1159/000538651. PubMedAbstract available
March 2024
PAN L, Zheng Y, Zheng H Long Non-coding RNA RP11-252C15.1 is a Potential Biomarker of Prognosis and
Hallmark for Leukemogenesis in Children with B-cell Precursor Acute Lymphoblastic
Leukemia.
Acta Haematol. 2024 Mar 25. doi: 10.1159/000535461. PubMedAbstract available
BENJAMINI O, Tadmor T, Avigdor A, Gershon R, et al Efficacy of preexposure prophylaxis with monoclonal-antibody
tixagevimab-cilgavimab against emerging SARS-CoV-2 resistant variants in patients
with chronic lymphocytic leukemia.
Acta Haematol. 2024 Mar 12. doi: 10.1159/000537690. PubMedAbstract available
SHAPIRA S, Hirschberger N, Ofran Y, Mizrahi B, et al The effect of mind-body intervention on lymphocyte doubling time and treatment
free survival in treatment-naive chronic lymphocytic leukemia patients.
Acta Haematol. 2024 Mar 8. doi: 10.1159/000538055. PubMedAbstract available
MORIGUCHI M, Ido K, Okamura H, Nakamae M, et al Impacts of Posttransplant Cyclophosphamide Dose on Graft-versus-leukemia Effects
via HLA-B Leader in HLA-haploidentical Peripheral Blood Stem Cell
Transplantation.
Acta Haematol. 2024 Mar 1. doi: 10.1159/000538078. PubMedAbstract available
February 2024
PARIGGER T, Drothler S, Scherhaufl C, Gassner FJ, et al Oncogenic MTOR signaling axis compensates BTK inhibition in a Chronic Lymphocytic
Leukemia patient with Richter Transformation: A Case Report and Review of the
Literature.
Acta Haematol. 2024 Feb 24. doi: 10.1159/000537791. PubMedAbstract available
LACHAINE J, Beauchemin C, Dodat F, Au Y, et al Evaluating the economic burden of acute myeloid leukemia in Canada.
Acta Haematol. 2024 Feb 21. doi: 10.1159/000537725. PubMedAbstract available
ZHANG Q, Dong Y, Zhai Z, Tao L, et al Lenalidomide treatment of isolated central nervous system relapse in acute
lymphoblastic leukemia after HSCT and CAR-T cell therapy.
Acta Haematol. 2024 Feb 15. doi: 10.1159/000537719. PubMedAbstract available
ZHONG T, Xu D, Li W Prevalence, risk factors, and prognostic value of anxiety and depression in acute
myeloid leukemia.
Acta Haematol. 2024 Feb 11. doi: 10.1159/000536457. PubMedAbstract available
January 2024
HU GH, Zhang XH, Liu KY, Xu LP, et al Outcome and prognostic factors of haploidentical allogeneic hematopoietic stem
cell transplantation in pediatric relapsed or refractory ETV6/RUNX1-positive
acute lymphoblastic leukemia.
Acta Haematol. 2024 Jan 20. doi: 10.1159/000536396. PubMedAbstract available
WACHTER F, Pikman Y Pathophysiology of Acute Myeloid Leukemia (AML).
Acta Haematol. 2024 Jan 16. doi: 10.1159/000536152. PubMedAbstract available
TROUSSARD X Unusual clinical presentations of hairy cell leukemia.
Acta Haematol. 2024 Jan 4. doi: 10.1159/000536043. PubMed
AL-SAWAF O Importance of Minimal Residual Disease in the Era of Targeted Therapies in
Chronic Lymphocytic Leukemia.
Acta Haematol. 2024;147:22-32. PubMedAbstract available
TADMOR T, Burger J Chronic Lymphocytic Leukemia: Novel Perspectives - How to Teach an Old Dog New
Tricks.
Acta Haematol. 2024;147:5-7. PubMed
KANG S, Ahn IE Prognostic Markers in the Era of Targeted Therapies.
Acta Haematol. 2024;147:33-46. PubMedAbstract available
GARGIULO E, Teglgaard RS, Faitova T, Niemann CU, et al Immune Dysfunction and Infection - Interaction between CLL and Treatment: A
Reflection on Current Treatment Paradigms and Unmet Needs.
Acta Haematol. 2024;147:84-98. PubMedAbstract available
CARLSON KS, Cunningham A, Stahl M, Winer E, et al Diagnostic Precision or Pitfalls: How to Apply the New Acute Myeloid Leukemia
Classification Systems?
Acta Haematol. 2024;147:122-132. PubMedAbstract available
JIMENEZ-CHILLON C, Dillon R, Russell N Optimal Post-Remission Consolidation Therapy in Patients with AML.
Acta Haematol. 2024;147:147-158. PubMedAbstract available
BUCHRITS S, Wolach O Non-Immunotherapy Approaches for Relapsed or Refractory AML: An Update for 2024.
Acta Haematol. 2024;147:159-174. PubMedAbstract available
MOLICA S, Rossi M, Allsup D Consensus Statements Highlight the Need of Harmonizing Chronic Lymphocytic
Leukemia Management Worldwide.
Acta Haematol. 2024;147:257-259. PubMedAbstract available
December 2023
DIGENNARO J, Sallman DA TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Current
Guidelines, Therapies and Future Considerations.
Acta Haematol. 2023 Dec 5. doi: 10.1159/000535628. PubMedAbstract available
November 2023
WOODS JD, Klepin HD Geriatric assessment in Acute Myeloid Leukemia (AML).
Acta Haematol. 2023 Nov 30. doi: 10.1159/000535500. PubMedAbstract available
SHIMONY S, Stone RM Untangling Complexities of Acute Myeloid Leukemia Review Series.
Acta Haematol. 2023 Nov 30. doi: 10.1159/000535574. PubMed
BLACKMON AL, Hourigan CS Test then erase? Current status and future opportunities for Measurable Residual
Disease testing in Acute Myeloid Leukemia.
Acta Haematol. 2023 Nov 30. doi: 10.1159/000535463. PubMedAbstract available
HOFFMAN T, Atamna A, Litchevsky V, Amitai I, et al Fluoroquinolone Prophylaxis During Conventional Chemotherapy or Hematopoietic
Stem Cell Transplantation for Acute Leukemia - Pros and Cons.
Acta Haematol. 2023 Nov 21. doi: 10.1159/000535119. PubMedAbstract available
COWEN EA, Barrios DM, Pulitzer MP, Moy AP, et al Acute febrile neutrophilic dermatosis (Sweet syndrome) in acute myeloid leukemia
patients: a 28-year institutional experience.
Acta Haematol. 2023 Nov 21. doi: 10.1159/000535399. PubMedAbstract available
RIOS-OLAIS FA, Gil-Lopez F, Mora-Canas A, Demichelis-Gomez R, et al Tumor lysis syndrome is associated with worse outcomes in adult patients with
acute lymphoblastic leukemia.
Acta Haematol. 2023 Nov 14. doi: 10.1159/000534453. PubMedAbstract available
ITO K, Harada K, Uchino Y, Hirano K, et al A Rare Clinical Case of Secondary Central Nervous System Involvement without
Transformation in Hairy Cell Leukemia: Case Report and Literature Review.
Acta Haematol. 2023 Nov 10. doi: 10.1159/000535066. PubMedAbstract available
ZHAO MN, Su L, Song F, Wei ZF, et al Shikonin exerts an anti-leukemia effect against FLT3-ITD mutated acute myeloid
leukemia cells via targeting FLT3 tyrosine kinase and its downstream pathways.
Acta Haematol. 2023 Nov 3. doi: 10.1159/000534101. PubMedAbstract available
October 2023
ARGUELLO-TOMAS M, Albiol N, Moreno C Frontline therapy in Chronic Lymphocytic Leukemia.
Acta Haematol. 2023 Oct 27. doi: 10.1159/000534730. PubMedAbstract available
SAUSSELE S, La Rosee P, Kiani A, Haverkamp W, et al Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of
Chronic Myeloid Leukemia.
Acta Haematol. 2023 Oct 17. doi: 10.1159/000533666. PubMedAbstract available
MINCULESCU L, Reekie J, Petersen SL, Kornblit BT, et al Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with
Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic
Stem Cell Transplantation.
Acta Haematol. 2023 Oct 12. doi: 10.1159/000534315. PubMedAbstract available
HAREL R, Itchaki G COVID-19 in Patients with Chronic Lymphocytic Leukemia - What Have We Learned?
Acta Haematol. 2023 Oct 11. doi: 10.1159/000534540. PubMedAbstract available
KATZ OB, Yehudai-Ofir D, Zuckerman T Cellular therapy in chronic lymphocytic leukemia: have we advanced in the last
decade?
Acta Haematol. 2023 Oct 9. doi: 10.1159/000534341. PubMedAbstract available
BELLO E, Liao H, Patel SA Clinico-Radio-Pathologic Correlation of Leukostasis in Acute Myeloid Leukemia
with FLT3 Mutation.
Acta Haematol. 2023 Oct 3. doi: 10.1159/000531832. PubMedAbstract available
September 2023
ALSHEMMARI SH, A Siddiqui M, Pandita R, Osman HY, et al Evidence-based Management of Chronic Lymphocytic Leukemia: Consensus Statements
from the Gulf Region.
Acta Haematol. 2023 Sep 26. doi: 10.1159/000531675. PubMedAbstract available
BAE S, Sa S, Park S, Cho BS, et al Limited efficacy of Venetoclax Combination Regimens in Acute Myeloid Leukemia
with Extramedullary Relapse.
Acta Haematol. 2023 Sep 26. doi: 10.1159/000534026. PubMedAbstract available
SASTOW D, Van Hyfte G, Feld J, Kremyanskaya M, et al Exclusion of Acute Myeloid Leukemia Patients with Central Nervous System
Involvement from Clinical Trials: An Analysis of the National Institutes of
Health Clinical Trials Registry from 2012-2022.
Acta Haematol. 2023 Sep 26:1. doi: 10.1159/000533819. PubMedAbstract available
KOEHRER S, Burger JA Chronic lymphocytic leukemia: disease biology.
Acta Haematol. 2023 Sep 16. doi: 10.1159/000533610. PubMedAbstract available
CHEN EC, Garcia JS Immunotherapy for acute myeloid leukemia: current trends, challenges, and
strategies.
Acta Haematol. 2023 Sep 6. doi: 10.1159/000533990. PubMedAbstract available
LEVY YURKOVSKI I, Tadmor T Accelerated Chronic Lymphocytic Leukemia and Richter Transformation in the Era of
Novel Agents.
Acta Haematol. 2023 Sep 4. doi: 10.1159/000533664. PubMedAbstract available
January 2023
HERSHENFELD SA, Atenafu EG, Chan S, Gupta V, et al Impact of Geographical Distance from Quaternary Treatment Center on Clinical
Trial Participation, Intensive Induction Chemotherapy, and Outcomes in Patients
with Newly Diagnosed Acute Myeloid Leukemia.
Acta Haematol. 2023;146:366-372. PubMedAbstract available
BURMEISTER T, Bullinger L, le Coutre P The Recurrent Atypical e8a2 BCR::ABL1 Transcript with Insertion of an Inverted 55
Base Pair ABL1 Intron 1b Sequence: A Detailed Molecular Analysis.
Acta Haematol. 2023;146:413-418. PubMedAbstract available
PAPADOPOULOU V, Schoumans J, Scarpelli I, Blum S, et al Description of an Institutional Cohort of Myeloid Neoplasms Carrying ETV6-Locus
Deletions or ETV6 Rearrangements.
Acta Haematol. 2023;146:401-407. PubMedAbstract available
TINAJERO J, Ngo D, Puing A, Koller P, et al Treatment Outcomes of Acute Myeloid Leukemia in Patients Living with Human
Immunodeficiency Virus Receiving Antiretroviral Therapy: A Single-Center
Experience.
Acta Haematol. 2023;146:490-495. PubMedAbstract available
TINAJERO J, Ngo D, Salhotra A, Koller P, et al Cladribine, Cytarabine, and Etoposide-Based Regimens Are Safe and Tolerable In
Relapsed and Refractory Acute Myeloid Leukemia Patients.
Acta Haematol. 2023;146:538-542. PubMedAbstract available